drugset
drugset / Trial / NCT03870113

DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2

NCT03870113 ↗

Phase 1 Unknown 80 enrolled Shenzhen People's Hospital
NaSingle-groupOpen-labelTreatment

Summary

To establish therapeutic dendritic cell (DC) vaccines targeting HPV 16/18 E6/E7 protein to block the progression of CIN1/CIN2 to cervical cancer and evaluate the safety and efficacy of the vaccines.

Timeline

Start
2019-04-01
Primary completion
2022-03-31
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject HPV 16/18 E6/E7- pulsed DC vaccines Vaccine — Other

Indications

cervical intraepithelial neoplasia